Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

Share Price is delayed by 15 minutes
Get Live Data
16.35    -0.10 (-0.61%)
Bid:
16.30
Ask:
16.45
Spread: 0.15 (0.92%)
Market Cap: £131.05m
ALL Live PriceLast checked at - London Stock Exchange

Intraday Atlantic Lithium Share Chart

Replacement Form 8 (OPD) Offeree

14 Oct 2014 10:10

RNS Number : 2307U
Allocate Software PLC
14 October 2014
 



 

 

Correction: Amendment to Section 3 of RNS 2086U replacing incorrect reference to Acorn Shares with Allocate Shares and Acorn Director with Allocate Director.

 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the party to the offer making the disclosure:

Allocate Software Plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each party to the offer

Allocate Software Plc

(d) Is the party to the offer making the disclosure the offeror or the offeree?

OFFEREE

(e) Date position held:

14 October 2014

(f) Has the party previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

NO

If YES, specify which:

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

5 pence Ordinary Shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

-

-

-

-

(2) Derivatives (other than options):

-

-

-

-

(3) Options and agreements to purchase/sell:

-

-

-

-

 

TOTAL:

Nil

Nil

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(c) Irrevocable commitments and letters of intent

 

Details of any irrevocable commitments or letters of intent procured by the party to the offer making the disclosure or any person acting in concert with it (see Note 3 on Rule 2.11 of the Code):

 

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe of any person acting in concert with the party to the offer making the disclosure:

 

Shares

Name

Number of Allocate shares¹

% of issued ordinary share capital of Allocate as at 14 October 2014

Terry Osborne

403,517

0.59

Ian Bowles

802,730

1.18

Chris Gale

65,429

0.10

Allen Swann

276,118

0.40

Richard King

50,000

0.07

Andrew Pringle

7,190

0.01

Total

1,604,984

2.35

 

 

¹. This number includes the number of Allocate Shares (if any) held by family members/trusts/nominees of the relevant Allocate Director to which the irrevocable also relates.

 

Options

 

Name

Name of share scheme

Number of shares

Grant date

Exercise price

Normal exercise period

Ian Bowles

LTRP

LTRP

LTRP

Bonus Option Scheme

 

400,000

300,000

300,000

150,000

1 December 2011

1 December 2011

1 December 2011

17 March 2014

Nil

Nil

Nil

116.5

10/14 - 30/11/17

09/15 - 30/11/17

09/16 - 30/11/17

17/03/15 - 16/03/24

Chris Gale

New CSOP

New Unapproved Option Scheme

 

27,972

105,361

15 August 2012

15 August 2012

71.5

71.5

09/15 - 14/08/22

09/15 - 14/08/22

 

Allen Swann

Bonus Option Scheme

New CSOP

New Unapproved Option Scheme

New Unapproved Option Scheme

 

50,000

 

27,972

105,361

 

50,000

17 March 2014

 

15 August 2012

15 August 2012

 

17 March 2014

 

116.5

 

71.5

71.5

 

116.5

17/03/15 - 16/03/24

 

09/15 - 14/08/22

09/15 - 14/08/22

 

09/16 - 16/03/24

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3 for each additional class of relevant security.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

14 October 2014

Contact name:

Chris Gale - Chief Financial Officer

 

Telephone number:

+44 (0) 20 7355 5555

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEEEANELFELLFEF
Date   Source Headline
15th Aug 20227:00 amRNSLodgement of Dual Listing Prospectus
11th Aug 20227:00 amRNSCorporate Update - PDMR - PCA Dealings
2nd Aug 20227:00 amRNSAssays Continue to Extend Mineralisation at Ewoyaa
28th Jul 20227:00 amRNSCorporate Update - Issue of Equity
19th Jul 20227:00 amRNSOngoing High Grade Drill Intersections at Ewoyaa
18th Jul 20227:00 amRNSCorporate Communication Update
12th Jul 20227:00 amRNSCorporate Update - Proposed Listing on ASX
11th Jul 202212:00 pmRNSAustralian Tax Information Statement - Amended
8th Jul 20223:00 pmRNSAustralian Tax Information Statement
23rd Jun 20227:00 amRNSInitial High-Grade Drill Intersections at Ewoyaa
13th Jun 20221:00 pmRNSCorporate Update - Extension of Option Expiry
7th Jun 20227:00 amRNSMetallurgical Profiling Continues to Deliver
1st Jun 20221:00 pmRNSCorporate Update - Issue of Equity
26th May 20227:00 amRNSExpanded Drilling Programme at Ewoyaa, Ghana
25th May 20221:00 pmRNSCorporate Update - Response to Media Articles
10th May 20227:00 amRNSCorporate Update - Issue of Equity
29th Apr 20227:00 amRNSCorporate Communications Update
29th Apr 20227:00 amRNSCorporate Communications Update
27th Apr 20227:00 amRNSCorporate Update – Resignation of Director
27th Apr 20227:00 amRNSCorporate Update - Notification of Major Holdings
22nd Apr 20227:00 amRNSBoard Commitment and Issue of Options
20th Apr 20227:00 amRNSDirector Dealings - Issue of Equity
12th Apr 202210:00 amRNSCorporate Update - PDMR / PCA Dealings
4th Apr 20221:00 pmRNSCorporate Update - Canaccord Appointment
31st Mar 20227:00 amRNSCorporate Update and Half-year Financial Report
29th Mar 20227:00 amRNSCorporate Update - Board Appointment - Len Kolff
24th Mar 20227:00 amRNSEwoyaa Mineral Resource Estimate Up 42% to 30.1Mt
21st Mar 20227:00 amRNSProposed Appointment of Interim CEO
17th Mar 20227:00 amRNSCommencement of Drilling Ghana
16th Mar 20227:00 amRNSCorporate Update – Board Appointment
10th Mar 20228:25 amRNSVale Vincent Mascolo - Passing of our CEO and MD
10th Feb 20227:00 amRNSFurther Lithium Infill Drilling Results, Ghana
25th Jan 20227:00 amRNSFurther Lithium Infill Drilling Results, Ghana
18th Jan 20227:00 amRNSFurther Lithium Infill Drilling Results, Ghana
24th Dec 20217:00 amRNSCompletion of Ricca Resources Limited Demerger
21st Dec 20213:50 pmRNSTR1 - Notification of Major Holdings
15th Dec 20217:00 amRNSInitial Lithium Infill Drilling Results, Ghana
7th Dec 20217:00 amRNSExceptional Lithium Scoping Study Update Ghana
3rd Dec 20217:00 amRNSCorporate Communication Update - Atlantic
1st Dec 20217:00 amRNSEwoyaa Mineral Resource Estimate Increases by 47%
26th Nov 20217:00 amRNSIssue of Options and New OTCQX Ticker 'ALLIF'
25th Nov 20217:00 amRNSRicca Resources - Gold Demerger - Dispatch of OIS
23rd Nov 20217:04 amRNSCorporate Communications Update
22nd Nov 20217:00 amRNSChange of Company Name and TIDM
12th Dec 20145:42 pmRNSHolding(s) in Company
9th Dec 20144:47 pmRNSUpdate: Cancellation of Listing
8th Dec 20143:15 pmRNSHolding(s) in Company
5th Dec 201412:35 pmRNSHolding(s) in Company
4th Dec 20145:40 pmRNSHolding(s) in Company
1st Dec 20146:29 pmRNSCompulsory Acqn of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.